Intellia Therapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 5,472 | 0.0% | 608,665 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 15,377 | 0.0% | 890,361 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 7,166 | 0.0% | 763,981 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 3,051 | 0.0% | 429,105 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 6,152 | 0.0% | 527,620 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 8,570 | 0.0% | 417,051 | 9/30/2024 |
| 2024 Q2 | 8/15/2024 | 4,938 | 0.0% | 220,638 | 6/30/2024 |
| 2024 Q1 | 5/7/2024 | 2,738 | 0.0% | 99,524 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 5,961 | 0.0% | 195,499 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 3,408 | 0.0% | 107,789 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 8,060 | 0.0% | 197,648 | 6/30/2023 |
| 2023 Q1 | 5/16/2023 | 5,352 | 0.0% | 143,602 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 4,335 | 0.0% | 124,255 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 6,443 | 0.0% | 115,126 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 4,096 | 0.0% | 79,141 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 4,380 | 0.0% | 60,279 | 3/31/2022 |
| 2021 Q4 | 2/14/2022 | 4,425 | 0.0% | 37,425 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 11,430 | 0.0% | 85,201 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 3,101 | 0.0% | 19,152 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 1,197 | 0.0% | 14,925 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 4,025 | 0.0% | 73,985 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 2,887 | 0.0% | 145,238 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 1,067 | 0.0% | 50,777 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 1,062 | 0.0% | 86,880 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 1,073 | 0.0% | 73,123 | 12/31/2019 |